Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

As many as 290 cases of <keyword id="21545939" type="General" weightage="20" keywordseo="KP-2" source="keywords">KP.2</keyword> and 34 cases of <keyword id="21748081" type="General" weightage="20" keywordseo="KP-1" source="keywords">KP.1</keyword>, both sub-lineages of COVID-19 that are responsible for surge in cases in Singapore, have been found in India, according to official data. However, a source in the Union health ministry told PTI that they are all sub variants of <keyword id="20115417" type="General" weightage="20" keywordseo="JN1" source="keywords">JN1</keyword> and there is no associated increase in hospitalisation and severe cases. "So there is no reason for concern or panic. The mutations will keep happening at a rapid pace and this is the natural behaviour of viruses like SARS-CoV2," the source said. The source further said that the INSACOG surveillance is sensitive and is able to pick up the emergence of any new variant and samples are also picked from hospitals in a structured manner to detect any change in the severity of disease due to virus. Data compiled by the Indian SARS-CoV-2 Genomics Consortium (INSACOG) showed that 34 cases of KP.1 have been found across seven states and UTs with 23 cases registered from West Bengal. The other states are Goa (1), Gujarat (2), Haryana (1), Maharashtra (4) Rajasthan (2) and Uttarakhand (1). As many as 290 cases of KP.2 have been registered with Maharashtra reporting the highest number at 148, according to the data. The other states and Union territories are Delhi (1), Goa (12), Gujarat (23), Haryana (3), Karnataka (4), Madhya Pradesh (1), Odisha (17), Rajasthan (21), Uttar Pradesh (8), Uttarakhand (16) and West Bengal (36). Singapore is seeing a new COVID-19 wave as the authorities recorded more than 25,900 cases from May 5 to 11 with KP.1 and KP.2 accounting for over two-thirds of cases in Singapore. Globally, the predominant COVID-19 variants are still JN.1 and its sub-lineages, including KP.1 and KP.2. KP.1 and KP.2 belong to a group of COVID-19 variants scientists have nicknamed 'FLiRT', after the technical names of their mutations. The strains in FLiRT are all descendants of the JN.1 variant, an offshoot of the Omicron variant. KP.2 was classified by the World Health Organization as a Variant Under Monitoring.

290 cases of COVID-19 variant KP.2, 34 cases of KP.1 detected in India: INSACOG data

Doctors in India are grappling to diagnose and treat unexplained and persistent symptoms of <keyword id="9814327" type="General" weightage="100" keywordseo="long-covid" source="Orion">long Covid</keyword> patients due to limited guidelines, whereas researchers have flagged inadequate studies on the condition. With the <keyword id="19896311" type="General" weightage="20" keywordseo="world-health-organization" source="keywords">World Health Organization</keyword> declaring an end to <keyword id="19896627" type="General" weightage="20" keywordseo="covid" source="keywords">Covid</keyword> as a global <keyword id="416511" type="General" weightage="20" keywordseo="health-emergency" source="Orion">health emergency</keyword> in May last year, focused efforts are underway around the world to estimate the burden of long Covid among the population. The condition refers to the set of lingering symptoms affecting varied body parts and persisting well beyond the acute Covid infection period, including cough, muscle and joint pain, fatigue, brain fog and difficulty in focusing. The viral disease is caused by the SARS-CoV-2 virus. While studies have suggested that about a third of those moderately or severely infected are likely to suffer from long Covid, region-wise though, incidence could vary. A study by researchers, including those from <keyword id="19988007" type="General" weightage="20" keywordseo="harvard-medical-school" source="keywords">Harvard Medical School</keyword>, US, estimated that 31 % of the once-infected people in North America, 44% in Europe, and 51% in Asia, have long Covid, which is "challenging the healthcare system, but there are limited guidelines for its treatment". It was published in the International Journal of Infectious Diseases in September. In India, however, studies on long Covid are few and far between. One such study by Maulana Azad Medical College in New Delhi, conducted from May 2022 to March 2023 on 553 patients who had recovered from Covid, found that about 45% had lingering symptoms, persistent fatigue and dry cough being the most common. "There is limited exploratory research on the long Covid syndrome with scarce data on long-term outcomes," the authors wrote in the study published in the journal Cureus in May this year. Understanding the long-term effects of the virus is important for developing management strategies, optimising healthcare delivery, and providing support to recovered Covid patients in the community, they said. Dr Rajesh Sagar, Professor of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, said, "Looking at the current state of long Covid studies in India, it is too premature to say that we understand the condition well enough to know how to diagnose or treat it." Animesh Samanta, assistant professor at School of Natural Sciences in <keyword id="19897094" type="General" weightage="20" keywordseo="shiv-nadar-university" source="keywords">Shiv Nadar University</keyword>, Greater Noida, said, "While studies in India highlight the growing recognition of neurological complications in long Covid patients, more focused research on neuroinflammation is needed." Doctors, too, have reported a rise in patients complaining of symptoms that they did not have pre-Covid. "People who never had <keyword id="6465125" type="General" weightage="20" keywordseo="asthma" source="Orion">asthma</keyword> in the past, post-Covid, with every viral infection, they get a long cough, shortness of breath and wheezing, which require the use of <keyword id="31257" type="General" weightage="20" keywordseo="inhalers" source="Orion">inhalers</keyword> or nebuliser," senior consultant Dr Neetu Jain, who runs a post-Covid care clinic at Pushpawati Singhania Hospital and Research Institute, New Delhi, said. Dr Arun Garg, chairman, Neurology and Neurosciences, Medanta-The Medicity, Gurugram, said he was noticing a spike in stroke cases among young patients not suffering from known risk factors such as diabetes, hypertension and obesity. "Similarly, we are seeing more cases of encephalopathy (swelling of the brain) without reason and having a confused state of mind following one or two days of fever. Their MRI scans show no changes. These patients have increased significantly after Covid," he said. In the absence of medical guidelines to diagnose long Covid, doctors are having to resort to broad, non-specific tests and questionnaires to gauge a patient's 'quality of life'. Studies have shown that the fatigue experienced in long Covid is similar to that in cancer patients, with a quality of life similar to patients of Parkinson's disease. "We really do not have any test to diagnose long Covid, even though it is definitely a clinical diagnosis. We diagnose long Covid for people who had at least moderate to severe infection, following which they could never regain the quality of life pre-Covid. Checking for inflammatory markers like C-reactive proteins (CRP) can support the diagnosis," Dr Jain said. "Other than routine blood tests that measure inflammation, we do antibody tests to look for direct markers. In many of these patients, we are finding rare antibodies which are very new to us and were not there pre-Covid," Dr Garg said. Inflammation persisting despite recovery from acute Covid infection is thought to lie at the heart of long Covid. However, tests to measure this specific immune response are lacking, even as researchers have been working in this direction worldwide. One such effort comes from Shiv Nadar University, where a team led by Samanta has developed a fluorescent probe capable of detecting inflammation in brain cells that can arise due to Covid infection. The probe measures nitric oxide levels in brain cells, especially in human microglia cells, where increased NO levels are linked to the SARS-CoV-2 infection. Microglia are immune cells in the brain that fight disease and help maintain brain health. Lysosomes within microglia, which help clear foreign disease-causing agents like the SARS-CoV-2 virus, produce nitric oxide as part of an immune response to infection. The probe detects nitric oxide produced in lysosomes in response to infection and thereby allows for a measurement of inflammation levels. This examination method can provide "qualitative information on infection status", said Samanta, corresponding author on the study published in the journal Analytical Chemistry in American Chemical Society. He explained that patients with pre-existing conditions such as Alzheimer's disease, Parkinson's disease or multiple sclerosis (an autoimmune disorder) could exhibit prolonged neuroinflammation and loss of brain cells following Covid infection. While the probe has shown efficacy in cell cultures, animal studies would need to be done, before testing it in humans, Samanta said. Looking at the World Health Organization International Clinical Trials Registry Platform, the study by Harvard Medical School had found that 587 clinical studies were conducted on long Covid, of which about 53% (312) were testing potential treatments. Most of these were found to be conducted in the US (58), followed by India (55) and Spain (20). The trials looked at interventions including physical exercise, psychotherapy, and pharmacological ones such as paxlovid and fluvoxamine. However, "to date, only 11 of these 312 studies have published their results that were not confirmative," the researchers wrote. The team called for studies to look into sleep disorders which were rarely included in the registered clinical studies. Further, interventions targeting the biological processes responsible for long Covid are needed but currently lacking, they said.

Doctors struggle to treat long Covid patients in India; researchers point to inadequate studies

<ul><li>The number of <keyword id="9426820" type="General" weightage="20" keywordseo="active-covid-cases" source="Orion">active Covid cases</keyword> in India surpassed the 10,000-mark for the first time in 134 days. </li><li>Delhi on Sunday reported 153 new Covid cases in the last 24 hours, and its positivity rate rose to 9.13%. </li><li>38 girl students of the Kasturba residential school in Lakhimpur Kheri of UP tested positive for Covid-19. </li></ul> India’s active Covid-19 cases are their highest they have been in the last 4.4 months, at 10,300 cases, according to Union health ministry data updated on Monday. The number of active cases surpassed the 10,000-mark for the first time in 134 days. On Sunday, the health ministry had put the count of active cases at 9,433. The daily positivity rate has been recorded at 3.19% and the weekly positivity rate at 1.39%. The Union Health Secretary Rajesh Bhushan will hold a meeting with States' health secretaries and senior officers on Monday evening, via video conferencing, to review the preparedness for Covid-19. A nationwide mock drill is being planned for April 10-11 in which health facilities from all the districts are expected to participate. The details of the drill will be communicated in the meeting today. There are a few states like Kerala, Maharashtra, Gujarat, Karnataka and Tamilnadu that have reported the maximum number of Covid-19 cases in the country. But hospitalization remains low in these states, said ANI. The Union health secretary highlighted the precautions that need to be taken by the people. The Union Health Secretary also mentioned that States should maintain the optimum testing for Covid-19 preparedness. 6 deaths reported in the last 24 hours Also, six deaths, one each reported by Chandigarh, Gujarat, Himachal Pradesh and Uttar Pradesh, and two in Kerala, in the last 24 hours. The total death toll now has increased to 5,30,837. Delhi on Sunday reported 153 new Covid cases in the last 24 hours, and its positivity rate rose to 9.13%. The capital city has 528 active cases, of which 340 patients are being treated in home isolation. The total tally of Covid cases across the country is 4.47 crore, the data stated. The active cases now comprise 0.02% of the total infections, while the national Covid recovery rate has been recorded at 98.79%, according to the health ministry's website. The number of people who have recuperated from the disease has increased to 4.41 crore, the data stated. The case fatality rate has been recorded at 1.19%, as per PTI. According to the ministry's website, 220.65 crore doses of Covid vaccine have been administered so far under the nationwide <keyword id="9257042" type="General" weightage="20" keywordseo="covid-vaccination" source="Orion">Covid vaccination</keyword> drive. 38 school girls test Covid positive in UP’s Lamkhimpur Kheri Thirty-eight girl students of the Kasturba residential school in Mitauli block of Uttar Pradesh's Lakhimpur Kheri district have tested positive for Covid-19 infection, a district health official said. Lakhimpur Kheri Chief Medical Officer (CMO), Santosh Gupta, said that one staff member was also found Covid-positive during a contact tracing exercise on Sunday after which the entire campus has been turned into a quarantine centre by the health department. This is the highest number of new Covid cases reported in a district in a day this year, as per IANS. (With agency inputs)

India’s active Covid cases cross 10,000 for the first time in 134 days; Union Secy to hold meeting

<keyword id="66" type="General" weightage="100" keywordseo="delhi" source="Orion">Delhi</keyword> hospitals are witnessing a spike in cases of the H3N2 virus that triggers symptoms like fever, cold and body aches, but in certain cases, leaves behind persistent cough making patients extremely weak, doctors said. There has been a nearly 150 per cent rise in patients coming to OPDs with such complaints, they said. Elaborating on the possible reasons behind the surge, Dr Viny Kantroo, Consultant, Respiratory, Critical Care and Sleep Medicine Consultant at Indraprastha Apollo Hospitals, said the outbreak could have been triggered due by seasonal change, mutation of the virus and the economy being fully open. "Children are going to school and they are transmitting it to the elderly. A lot of cross-country travel is happening. In the last two years, <keyword id="8764262" type="General" weightage="80" keywordseo="covid" source="Orion">Covid</keyword> was the dominant virus and there were restrictions but with the relaxation of norms and return of normalcy, these outbreaks are being observed," she opined. Delhi government's LNJP Hospital has set up a 20-bed isolation ward in the emergency block for such patients. In accordance with the ICMR guidelines, we have done so and also stocked up on medicines. A 15-doctor team has been constituted to monitor the patients, said a senior doctor. Dr <keyword id="5518347" type="General" weightage="80" keywordseo="rajiva-gupta" source="Orion">Rajiva Gupta</keyword>, Senior Consultant - <keyword id="329004" type="General" weightage="80" keywordseo="internal-medicine" source="Orion">Internal medicine</keyword> at the CK Birla Hospital, Gurugram and Delhi, said the ILI (Influenza-like illness) cases have seen a spike in the last few days. "For instance, if we were seeing two to three patients in OPDs last month, this month there is one-and-a-half times rise. The symptoms are fever, discomfort, cold, and body aches. In some cases, patients also experience abdominal discomfort, diarrhoea, and even fullness in ears," he added. The senior doctor said the treatment approach changes lightly when the patient has comorbidities and stressed that in those cases, they ask the family members to monitor the BP, pulse, oxygen saturation levels and consciousness levels. "If these levels fluctuate, the patient needs hospitalisation," he stressed. Explaining the current strain, Dr Vikas Deswal, Senior Consultant, Internal Medicine, Medanta, Gurugram said the influenza virus is the most prevalent virus that affects our respiratory system and is present in three different types: A, B, and C. "Among these, subtype A is the most commonly found. One subtype of the influenza A virus is H3N2, which produces symptoms similar to other flu viruses such as cough, fever, cold, sore throat, fatigue, muscle pain, and respiratory complications, especially in children under two years, the elderly, and those with other medical conditions," he said. Both the doctors said in some cases, it has been observed that patients have persistent coughs even after the fever subsides. "One of my patients said he was having a persistent cough and could not attend meetings because of it. Patients also develop extreme weakness due to it," said <keyword id="6356160" type="General" weightage="80" keywordseo="gupta" source="Orion">Gupta</keyword>. Deswal cautioned against letting down a guard at this time and said since viruses mutate over time, it is important to take precautions. "Antibiotics are not effective in treating viral infections such as H3N2 and can be harmful, so people should avoid taking them, especially if they have H3N2. "The virus spreads through droplets and direct contact, so it is recommended to follow precautions such as avoiding touching surfaces, washing hands, following Covid-appropriate behaviour, practising social distancing, wearing masks, and avoiding going out if experiencing viral symptoms. Additionally, it is important for people to get vaccinated against influenza every year," he said. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/auto/news/general-motors-may-bring-chatgpt-like-digital-assistant-for-cars/articleshow/98634875.cms">General Motors may bring ChatGPT-like digital assistant for cars</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/startups/news/mos-it-to-take-up-svb-linked-startups-woes-with-finmin-pitches-for-indian-banks/articleshow/98635142.cms">MoS IT to take up SVB linked startups woes with FinMin; pitches for Indian banks</a>

Delhi hospitals witnessing spike in H3N2 cases, say doctors

Amid a spike in <keyword id="64895" type="General" weightage="20" keywordseo="Dengue-cases" source="Orion">dengue cases</keyword> in the national capital, many people down with viral infection are exhibiting "overlapping symptoms" of COVID-19 and the vector-borne disease, leaving both patients and doctors perplexed about the exact diagnosis. Cases of vector-borne diseases are usually reported between July and November, sometimes stretching till mid-December. Its symptoms include high fever, headache, rash and muscle and joint pain, which are quite similar to that of COVID-19 which also includes fever or chills, muscle or body aches, fatigue and headache among others. In such a situation it has become difficult to ascertain whether a person suffering from fever, body ache and headache is <keyword id="8764262" type="General" weightage="100" keywordseo="covid" source="Orion">Covid</keyword> positive or not, doctors said. "Covid cases are declining right now, but the virus is still there. I am still seeing Covid cases in my OPD. In the last 3-4 days, two cases were detected in OPD and one later in an ICU. However, on an average, dengue infection is on rise right now," said Dr Suranjit Chatterjee, a senior consultant at <keyword id="56368" type="General" weightage="50" keywordseo="apollo-hospitals" source="Orion">Apollo Hospitals</keyword>. "There are a few overlapping symptoms when it comes to both dengue and Covid, such as fever, bodyache and headache, and in such cases diagnosis cannot be that black and white. So, we are prescribing both Covid and dengue test to ascertain the exact infection. In fact, in some cases, even malaria and typhoid tests are also being done," he said. However, if a patient is suffering more from sore throat and cough and their fever is not very high, then Covid infection is more probable. So, a dengue test is not being prescribed in cases "where we can differentiate from the nature of symptoms," Chatterjee added. Doctors at many government and private hospitals are reporting a rise in footfall in OPDs after a continuous spike in dengue cases in <keyword id="66" type="General" weightage="50" keywordseo="delhi" source="Orion">Delhi</keyword> in the past two weeks. Most of the patients are complaining of fever, cough, sore throat and body ache or headache or both. Lok Nayak Jai Prakash (LNJP) Hospital - Delhi government's largest hospital and the main COVID-19 facility - is also reporting dengue cases with some of the patients being admitted after their platelets level had fallen beyond the normal range. Dengue fever can result in a drop in white blood cell and platelet counts. The normal platelet count in the body ranges from 1.5 to 4 lacs, which can go down to as low as 20,000 to 40,000 in the case of dengue patients. "Yes, rising dengue cases are making diagnosis difficult now. Earlier, we would analyse symptoms and Covid test would be prescribed if they had fever or other matching symptoms. Now not only patients, but even doctors are confused about the exact ailment due to their overlapping symptoms," a senior doctor at the hospital said. Over 520 dengue cases have been reported in Delhi this year till September 21, as per the data shared by the Municipal Corporation of Delhi (MCD). According to a report released by the civic body on September 26, as many as 281 cases have been reported this month alone till September 21. The spurt in dengue cases in the national capital has come after Delhi was lashed by incessant rains recently. 106 cases of malaria and 20 cases of chikungunya have also been reported this year in Delhi in the same period, the report said. Of the 525 total cases recorded till September 21 this year, 75 were reported in August, which is the highest number of dengue cases logged between January 1 to September 21 since 2017, when the corresponding figure was 1,807. Malaria, dengue and chikungunya are accompanied by high-grade fever and, therefore, doctors feel that people might think that they have contracted COVID-19, or even vice-versa. Chatterjee said many people are reluctant to get the COVID-19 test done, fearing they will have to go in isolation as they want to "go on with their lives". "So, given the slump in daily Covid cases in Delhi and rise in dengue cases, many are assuming that if they have fever or sore throat or body ache, it is either regular viral infection or something else, but not Covid. But, it could be Covid too, as the coronavirus is still amidst us," he cautioned and urged people to get themselves tested for Covid too if symptoms persist. At many workplaces, employees continue to work despite having cough, cold or sore throat, while earlier when the <keyword id="8785701" type="General" weightage="20" keywordseo="Covid-19-cases" source="Orion">COVID-19 cases</keyword> were on the rise, it would have been a strict no-no with an option of a 'work from home' regimen given to them, doctors said. "But, I would urge people to not assume any kind of fever as a regular flu, if their symptoms are prolonged and intense, consult a doctor," Chatterjee added. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/science/space/news/nasa-pushes-back-artemis-i-moon-mission-launch-to-november/articleshow/94596902.cms">NASA pushes back Artemis I Moon mission launch to November</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/telecom/news/sterlite-technologies-launches-optical-solution-for-5g-rollout/articleshow/94598884.cms">Sterlite Technologies launches optical solution for 5G rollout</a>

Overlapping symptoms of dengue, Covid-19 confusing in many cases, say doctors

New Delhi [India], April 23 (ANI): India reported over 10,000 COVID cases for the fifth straight day with 10,112 <keyword id="7571551" type="General" weightage="20" keywordseo="new-infections" source="Orion">new infections</keyword> in the last 24 hours, according to the Union Minister of Health and Family Welfare on Sunday. The country saw a little dip from Saturday's COVID cases tally. India recorded 12,193 on April 22, 11,692 on April 21, 12,591 on April 20, 10,542 on April 19, 7,633 on April 18, and 9,111 on April 17. According to the Union Health Ministry, the country's active cases increased to 67,806 which was 67,556 yesterday. Presently recovery rate stands at 98.66 per cent, the Health Ministry stated further. As many as 9,833 patients recovered from the disease in the last 24 hours taking the overall count of people cured of the infection to 4,42,92,854, according to the Ministry. Under the nationwide vaccination drive, India has so far administered 220.66 crore Covid vaccine doses (95.21 cr second doses and 22.87 cr precautionary doses), of which 1,947 doses were administered in the last 24 hours. The total number of tests conducted in the last 24 hours is 1,43,899, the health ministry stated. In wake of the spike in the number of COVID-19 cases across the country, Dr PK Mishra, the Principal Secretary to the Prime Minister earlier chaired a high-level meeting on Wednesday to assess the situation. The PMO informed in a statement that the focus of the meeting was on the status of preparedness of health infrastructure and logistics, drugs, vaccination campaign in the country and the key necessary steps as a response to the recent surge in Covid cases. "Dr PK Mishra stressed that the time tested 5-fold strategy of Test-Track-Treat-Vaccination and adherence COVID Appropriate Behaviour must continue to be implemented and equally crucial to promote awareness within the community regarding COVID appropriate behaviour and caution citizens against complacency," the PMO statement read. During the meeting, a comprehensive presentation was made by Rajesh Bhushan, the Secretary of Health and Family Welfare providing an overview of the global COVID-19 situation. The presentation also provided an overview of the Genome Sequencing of different variants since January 2023 and noted the proportion of circulating variants in India. The status of vaccination was discussed, followed by drug availability and infrastructure preparedness across the country, the PMO stated. As per directions of the Prime Minister, a nationwide mock drill for the assessment of functional infrastructure was conducted and the status of the mock drill was presented to participants. Further, the expenditure of the COVID-19 vaccination programme and budget provisions for drugs and vaccine raw materials were also reviewed. (ANI)

India reports over 10,000 COVID cases for fifth straight day

New Delhi [India] March 30 (ANI): A total of 3016 new <keyword id="8869954" type="General" weightage="20" keywordseo="covid-cases" source="Orion">Covid cases</keyword> were recorded in the last 24 hours across the country with a daily positive rate of 2.73 per cent, a government release said on Thursday, adding that 15,784 doses of COVID vaccines were administered during the same period. According to the release, 1,10,522 tests were conducted in the last 24 hours, taking the total number of tests conducted so far to 92.14 crores. It stated further that a total of 1,396 recoveries were made from the virus in the last 24 hours, taking the total number of recoveries to 4,41,68,321. It stated that 220.65 cr total vaccine doses (95.20 cr Second Dose and 22.86 cr Precaution Dose) have been administered so far under Nationwide Vaccination Drive. Further, India's active caseload currently stands at 13,509 with a rate of 0.03 per cent per day and with a recovery rate currently standing at 98.78 per cent. It stated that the weekly positivity rate stands at 1.71 per cent. Meanwhile, Delhi Health Minister Saurabh Bhardwaj called an emergency meeting on Thursday afternoon after 300 fresh Covid-19 cases were recorded in the Capital on Wednesday. "Health Minister Saurabh Bhardwaj will hold a meeting with the officers and specialist doctors associated with the health department this afternoon," officials said. The Special Secretary, Health Department, Director of General Health Services, Nodal Officer for Oxygen and Testing and Medical Directors of several hospitals including Lok Nayak Jai Prakash Narayan (LNJP) will be present in the meeting. The country recorded new 2151 Covid cases between Tuesday and Wednesday with a daily positive rate of 1.51 per cent, an official statement said on Wednesday, adding that 11,336 doses of vaccines were administered in the last 24 hours. Meanwhile, Delhi recorded 300 fresh Covid-19 cases and two deaths on Wednesday, marking a sharp uptick in infections over the last 24 hours. According to a bulletin issued by the Delhi Health department on Wednesday, the capital registered two deaths from Covid over the last 24 hours. The Ministry of Health and Family Welfare issued revised guidelines for Covid-19 in the wake of the surge of cases in the past week across the country. "Antibiotics should not be used unless there is clinical suspicion of bacterial infection. The possibility of coinfection of COVID-19 with other endemic infections must be considered. Systemic corticosteroids are not indicated in mild disease," revised guidelines said. As per the revised Covid-19 guidelines, maintain "Physical distancing, indoor mask use, hand hygiene, Symptomatic management (hydration, antipyretics, antitussive) Monitor temperature and oxygen saturation (by applying a SpO probe to fingers) Stay in contact with the treating physician. "Seek immediate medical attention if difficulty breathing, High-grade fever/ severe cough, particularly if lasting for more than 5 days. A low threshold is to be kept for those with any of the high-risk features," guidelines discussed and prepared in January said. Additionally, in moderate or severe diseases at high risk of progression, the guidelines recommend, "Consider Remdesivir for up to 5 days (200 mg IV on day 1 followed by 100 mg IV OD for the next 4 days)". SEE ALSO: <a href="https://www.businessinsider.in/tech/mobile/news/moto-g13-vs-realme-c55-mobile-phones-comparison-of-price-specification-and-features/slidelist/99106985.cms">Moto G13 vs Realme C55 – price, specs, and features compared</a> <a href="https://www.businessinsider.in/tech/news/here-are-the-jobs-chatgpt-says-ai-can-take-from-humans/slidelist/99087522.cms">We asked ChatGPT about jobs that AI can take over from humans – This was its answer</a> <a href="https://www.businessinsider.in/business/startups/news/zomato-gold-swiggy-dineout-competitor-eazydiner-raises-40-crore/articleshow/99091065.cms">EazyDiner raises ₹40 crore from DMI Alternative Investment Fund</a>

India reports 3,016 new Covid-19 cases, daily positive rate at 2.7%

The number of cases of COVID-19's <keyword id="15929505" type="General" weightage="20" keywordseo="XBB-1-5-variant" source="Orion">XBB.1.5 variant</keyword>, responsible for the rise in cases in the US, has gone up to 26 in India, according to INSACOG data on Monday. The cases of XBB.1.5 variant have been found across 11 states and Union territories till now, including <keyword id="66" type="General" weightage="20" keywordseo="delhi" source="Orion">Delhi</keyword>, <keyword id="13126" type="General" weightage="20" keywordseo="maharashtra" source="Orion">Maharashtra</keyword> and <keyword id="6357783" type="General" weightage="20" keywordseo="west-bengal" source="Orion">West Bengal</keyword>, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) said. The XBB.1.5 strain is a relative of the <keyword id="1609796" type="General" weightage="50" keywordseo="omicron" source="Orion">Omicron</keyword> XBB variant, which is a recombinant of the Omicron BA.2.10.1 and BA.2.75 subvariants. Combined, XBB and XBB.1.5 make up 44 per cent of cases in the US. The INSACOG data also showed that 14 cases of BF.7 strain which is apparently driving China's COVID-19 wave have been found in India. There are four cases of Omicron sub-variant BF.7 reported in West Bengal, three in Maharashtra, two each in Haryana and Gujarat and one each in Odisha, Delhi and <keyword id="6354780" type="General" weightage="50" keywordseo="karnataka" source="Orion">Karnataka</keyword>. INSACOG reports genomic surveillance of SARS-CoV-2 across the country through sequencing of samples from sentinel sites and international passengers arriving in India. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/news/google-cci-penalty-case-will-you-put-in-same-regime-as-in-europe-sc-asks-google/articleshow/97027578.cms">Google-CCI penalty case: 'Will you put in same regime as in Europe', SC asks Google</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/thelife/personalities/news/ruchir-modi-lalit-modis-son-named-as-his-successor/slidelist/97023203.cms">The rise of the Lalit Modi heir: All about Ruchir Modi, son &amp; successor of IPL founder</a>

You Searched For "covid cases in delhi" and got 8 results

290 cases of COVID-19 variant KP.2, 34 cases of KP.1 detected in India: INSACOG data

PTI

Doctors struggle to treat long Covid patients in India; researchers point to inadequate studies

Business Insider India

India’s active Covid cases cross 10,000 for the first time in 134 days; Union Secy to hold meeting

BI India Bureau

Delhi hospitals witnessing spike in H3N2 cases, say doctors

PTI

Overlapping symptoms of dengue, Covid-19 confusing in many cases, say doctors

PTI

India reports over 10,000 COVID cases for fifth straight day

ANI

India reports 3,016 new Covid-19 cases, daily positive rate at 2.7%

ANI

Covid 19's XBB.1.5 variant cases rise to 26 in India: INSACOG

PTI

Popular Keywords

Buying Guides